Rhetan TMT Intrinsic Value
Rhetan TMT (RHETAN) median intrinsic value is ₹9.14 from 9 valuation models (range ₹9–₹15), vs current price ₹30.47 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Browse RHETAN annual financials for revenue, profit, balance sheet and cash flow data.
RHETAN Valuation Methods Summary — DCF, Graham Number & P/E
Rhetan TMT intrinsic value across 9 models vs current price ₹30.47 — upside/downside and value range per method. For current market price and key ratios, visit Rhetan TMT stock price NSE.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹9.14 | ₹7.31 - ₹10.97 | -70.0% | EPS: ₹0.18, Sector P/E: 12x |
| Book Value Method | asset | ₹13.62 | ₹12.26 - ₹14.98 | -55.3% | Book Value/Share: ₹13.62, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹9.14 | ₹8.23 - ₹10.05 | -70.0% | Revenue/Share: ₹3.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹12.19 | ₹10.97 - ₹13.41 | -60.0% | EBITDA: ₹7.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹12.19 | ₹9.75 - ₹14.63 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹9.14 | ₹8.23 - ₹10.05 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹9.14 | ₹8.23 - ₹10.05 | -70.0% | Revenue Growth: -22.6%, Adj P/E: 8.0x |
| ROE Based Valuation | profitability | ₹15.23 | ₹13.71 - ₹16.75 | -50.0% | ROE: 9.2%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹9.14 | ₹8.23 - ₹10.05 | -70.0% | EPS: ₹0.18, BVPS: ₹13.62 |
RHETAN Intrinsic Value vs Market Price — All Valuation Models
Rhetan TMT fair value range ₹9–₹15 vs current market price ₹30.47 across 9 valuation models. Also explore RHETAN price movement history to track price trends across different timeframes.
RHETAN Intrinsic Value Analysis — Undervalued or Overvalued?
Rhetan TMT median intrinsic value ₹9.14, current price ₹30.47 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.
What is the intrinsic value of RHETAN?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Rhetan TMT (RHETAN) is ₹9.14 (median value). With the current market price of ₹30.47, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹9.14 to ₹15.23, indicating ₹9.14 - ₹15.23.
Is RHETAN undervalued or overvalued?
Based on our multi-method analysis, Rhetan TMT (RHETAN) appears to be trading above calculated value by approximately 70.0%.
RHETAN Financial Health — Key Ratios vs Industry Benchmarks
Rhetan TMT financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 4.59 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 9.2% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 27.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.15x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
RHETAN Cash Flow Quality — Operating & Free Cash Flow
Rhetan TMT operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹5 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹14 Cr | ₹10 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹-44 Cr | ₹-45 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-14 Cr | ₹-14 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹-7 Cr | ₹-7 Cr | Negative Cash Flow | 3/10 |